Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Doloresz Katanich

AstraZeneca quarterly net profit rises 2% on strong cancer drug sales

The share price of Cambridge-based pharmaceutical company AstraZeneca rose in European trading on Monday after the company reconfirmed its full-year outlook following second-quarter results that beat analyst expectations.

Net profit climbed more than 2% to $2.51 billion (€2.2bn) in the three months to the end of June compared with the same period last year, driven by continued strong growth in sales of its cancer medicines.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.